Plasmatology

Scope & Guideline

Transforming Hematology Through Innovative Studies

Introduction

Welcome to the Plasmatology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Plasmatology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2634-8535
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2021 to 2024
AbbreviationPLASMATOLOGY / Plasmatology
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Plasmatology' serves as a comprehensive platform for advancing knowledge and research in the field of plasma science and its applications in medicine. The main aims and scopes of the journal are centered around the biochemical, therapeutic, and clinical implications of plasma-derived products and therapies.
  1. Biochemical Characterization:
    Research focused on the biochemical properties and functional characteristics of plasma components, including growth factors, anticoagulants, and other proteins.
  2. Clinical Applications:
    Studies addressing the clinical use of plasma products in treating various conditions, including hematological diseases, immune disorders, and complications arising from treatments.
  3. Innovative Therapeutic Strategies:
    Exploration of new therapeutic approaches utilizing plasma, such as CRISPR technologies, plasma exchange techniques, and novel purification processes.
  4. Public Health and Policy Insights:
    Research evaluating the implications of plasma management in healthcare settings, including blood product utilization, health equity, and access to therapies.
  5. Case Studies and Retrospective Analyses:
    Detailed examinations of specific clinical cases or retrospective studies that provide insights into the effectiveness and challenges associated with plasma therapies.
The journal 'Plasmatology' is witnessing emerging trends that reflect the evolving landscape of plasma research and its applications. These themes highlight the journal's adaptation to contemporary medical challenges and innovations.
  1. Genetic and Molecular Approaches:
    An increasing focus on genetic analysis and molecular mechanisms, such as CRISPR and other gene-editing technologies, showcases the integration of cutting-edge science into plasma therapy.
  2. COVID-19 Related Research:
    A significant rise in studies related to COVID-19, particularly the therapeutic use of convalescent plasma and vaccine-related antibody responses, reflects the pandemic's influence on plasma research.
  3. Patient-Centric Studies:
    A trend towards research that emphasizes patient outcomes, quality of life, and health equity indicates a growing recognition of the importance of patient perspectives in plasma-related therapies.
  4. Interventional Studies:
    There is a notable increase in clinical trials and interventional studies assessing the efficacy of plasma therapies for various diseases, highlighting a shift towards evidence-based practice in plasma medicine.
  5. Public Health and Resource Management:
    Emerging themes around the management of plasma resources, including ethical considerations and policy implications, suggest a growing emphasis on the systemic aspects of plasma utilization in healthcare.

Declining or Waning

While 'Plasmatology' continues to thrive in several research areas, certain themes have shown a decline in prominence over recent publications. These waning scopes may reflect shifts in research focus or emerging priorities within the field.
  1. Historical Case Reports:
    There has been a noticeable decrease in the publication of traditional case reports, as the journal appears to be focusing more on innovative research and broader clinical implications rather than isolated clinical narratives.
  2. Basic Science Studies:
    Research that delves into the fundamental science of plasma components without direct clinical application seems to be waning, possibly due to a preference for studies that bridge the gap between bench and bedside.
  3. Exploratory Studies on Rare Conditions:
    Investigations into less common plasma-related conditions or niche therapeutic applications are becoming less frequent, indicating a potential shift towards more prevalent clinical issues.

Similar Journals

THERAPEUTIC APHERESIS AND DIALYSIS

Advancing the frontiers of hematology and nephrology.
Publisher: WILEYISSN: 1744-9979Frequency: 6 issues/year

THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.

Hematology Reports

Advancing knowledge in blood disorders.
Publisher: MDPIISSN: 2038-8322Frequency: 4 issues/year

Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.

Mediterranean Journal of Hematology and Infectious Diseases

Fostering innovation in medical research for a healthier tomorrow.
Publisher: MATTIOLI 1885ISSN: Frequency: 1 issue/year

Mediterranean Journal of Hematology and Infectious Diseases is a distinguished open access journal published by MATTIOLI 1885, dedicated to advancing the field of hematology and infectious diseases. Since its inception in 2009, the journal has provided a platform for researchers and practitioners to disseminate innovative findings, foster scholarly discourse, and enhance our understanding of these critical medical disciplines. With an impact factor reflecting its scholarly influence, it is recognized in the Q3 quartile for both Hematology and Infectious Diseases categories as of 2023. The journal's commitment to open access ensures that high-quality research is accessible to a global audience, contributing to the improvement of clinical practices and public health. Located in Fidenza, Italy, the journal continues to support converged research efforts from 2010 to 2024, making it an essential resource for academics, clinicians, and students in the medical community.

Plasma and Fusion Research

Igniting Innovation in Plasma and Fusion Research
Publisher: JAPAN SOC PLASMA SCIENCE & NUCLEAR FUSION RESEARCHISSN: 1880-6821Frequency: 2 issues/year

Plasma and Fusion Research is a pivotal journal within the realm of plasma science and nuclear fusion, published by the Japan Society of Plasma Science and Nuclear Fusion Research. With an ISSN of 1880-6821, this journal serves as a vital platform for disseminating significant research findings and advancements from Japan and around the globe. Operating since 2006, it has steadily contributed to the field, reflected in its recognition as a Q3 journal in Condensed Matter Physics for the year 2023 and its ranking of #383 out of 434 in the Scopus categories, placing it in the 11th percentile. Although it currently does not offer open access, the journal's commitment to quality research makes it essential reading for researchers, professionals, and students keen on exploring the complexities of plasma dynamics, fusion technology, and their applications in energy production. Situated in Nagoya, Japan, the journal fosters a collaborative environment aimed at pushing the boundaries of knowledge in plasma physics and enhancing the understanding of fusion processes.

CONTRIBUTIONS TO PLASMA PHYSICS

Elevating Knowledge in Plasma Physics Since 1988
Publisher: WILEY-V C H VERLAG GMBHISSN: 0863-1042Frequency: 10 issues/year

CONTRIBUTIONS TO PLASMA PHYSICS is a distinguished journal dedicated to advancing the field of plasma physics, published by WILEY-V C H VERLAG GMBH. Since its inception in 1988, this journal has provided a platform for high-quality research, fostering collaboration and dissemination of knowledge in the condensed matter physics domain. With its current ranking of Q3 in the 2023 assessments, the journal is recognized for its contributions to the discipline, as indicated by its position in the Scopus rankings (Rank #252/434) and 42nd percentile within its category. Researchers and professionals engaged in plasma physics are encouraged to submit their work, as the journal aims to publish innovative studies that push the boundaries of current understanding and application in plasma phenomena. While currently not offering open access, the journal remains a vital resource for insights into the complexities and advancements in plasma research, operating from its base in Germany.

Transfusionsmedizin

Elevating transfusion practices through peer-reviewed excellence.
Publisher: GEORG THIEME VERLAG KGISSN: 2191-8805Frequency: 4 issues/year

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

PHYSICS OF PLASMAS

Innovating the Future of Plasma Research
Publisher: AIP PublishingISSN: 1070-664XFrequency: 1 issue/year

Physics of Plasmas is a premier peer-reviewed journal published by AIP Publishing, focusing on the vital and interdisciplinary field of plasma physics. With an ISSN of 1070-664X, this journal presents cutting-edge research that spans a wide array of topics including fusion energy, astrophysical plasmas, and industrial applications of plasma technologies. As a recognized leader in the field, it holds a prestigious Q1 ranking in Condensed Matter Physics, reflecting its high impact and quality of published work. The journal's scope encompasses both fundamental studies and innovative applications, serving as an essential resource for researchers, professionals, and students alike. Although it does not offer open access, its rigorous selection process ensures that only the most significant contributions are highlighted. With a convergence of expertise from 1994 to 2024, Physics of Plasmas continually shapes the future of plasma research and technology, making it a critical avenue for sharing discoveries and advancements in this dynamic area of physics.

JOURNAL OF CLINICAL APHERESIS

Advancing Apheresis: Transforming Patient Care Through Innovation
Publisher: WILEYISSN: 0733-2459Frequency: 6 issues/year

JOURNAL OF CLINICAL APHERESIS, published by WILEY, serves as a premier platform for disseminating cutting-edge research in the specialized field of apheresis and its clinical applications. Established in 1982, this journal has been a vital resource for healthcare professionals, researchers, and students, focusing on innovative techniques, advancements in clinical practices, and the therapeutic use of apheresis in hematology and other medical disciplines. With an ISSN of 0733-2459 and E-ISSN 1098-1101, the journal is indexed in various databases, reflecting its solid academic reputation. Currently positioned in the Q3 quartile rankings for both Hematology and Miscellaneous Medicine categories, it offers insightful views into evolving methodologies and case studies that significantly impact patient care. Despite not being open access, the journal remains highly regarded within its community, ensuring that essential findings reach those dedicated to improving clinical outcomes in apheresis practices. Researchers and healthcare professionals are encouraged to engage with its comprehensive studies and foster further advancements in the field.

VOX SANGUINIS

Fostering Collaboration in Hematological Research
Publisher: WILEYISSN: 0042-9007Frequency: 12 issues/year

VOX SANGUINIS is a distinguished peer-reviewed journal in the fields of Hematology and Medicine, published by Wiley, a leading academic publisher based in the United Kingdom. With a rich history dating back to its inception in 1952, this journal has consistently provided a platform for innovative research and insightful reviews, advancing the understanding of blood-related disorders and therapies. As evidenced by its robust performance—ranking #57 out of 137 in Scopus for Medicine in Hematology and holding a Q2 classification in both Hematology and miscellaneous Medicine categories—VOX SANGUINIS is recognized for its significant contributions to the scientific community. This journal serves as a vital resource for researchers, professionals, and students alike, fostering knowledge exchange and collaboration within the field. With its ongoing commitment to quality and integrity, VOX SANGUINIS continues to shape the future of hematological research well into 2024 and beyond.

PLASMA SCIENCE & TECHNOLOGY

Pioneering Insights in Condensed Matter Physics
Publisher: IOP Publishing LtdISSN: 1009-0630Frequency: 12 issues/year

PLASMA SCIENCE & TECHNOLOGY is a distinguished academic journal published by IOP Publishing Ltd, focusing on the realm of condensed matter physics. With its inception in 2000 and continuing through 2024, the journal serves as a vital platform for disseminating groundbreaking research and developments in plasma science, encompassing experimental and theoretical studies that advance our understanding of plasma behavior and its applications. Although the journal is not open access, its insights are invaluable for researchers, professionals, and students devoted to the intricate physics of plasmas, particularly given its respectable Q2 quartile ranking within its category as of 2023 and a notable Scopus rank that places it within the 44th percentile among its peers. Published from the United Kingdom, the journal aims to foster collaboration and innovation in this essential field of study.